miR-429 inhibits migration and invasion of breast cancer cells in vitro
暂无分享,去创建一个
Yun Xiao | Chao Jing | Zhi‐hua Liu | Kai Gao | Z. Ye | Gang Ma | Yahui Zhao | Yun Zhan | Sheng-ji Yu | ZHI-BIN YE | GANG MA | YA-HUI ZHAO | YUN XIAO | YUN ZHAN | CHAO JING | KAI GAO | ZHI-HUA LIU | SHENG-JI YU | Zhihua Liu | Zhi-bin Ye | Gang Ma | Ya-hui Zhao | SHENG-JI Yu
[1] Yongwei Yu,et al. miR‐663 Induces Castration‐Resistant Prostate Cancer Transformation and Predicts Clinical Recurrence , 2014, Journal of cellular physiology.
[2] X Wang,et al. Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer , 2014, Oncogene.
[3] You-hong Cui,et al. Primate-Specific miR-663 Functions as a Tumor Suppressor by Targeting PIK3CD and Predicts the Prognosis of Human Glioblastoma , 2014, Clinical Cancer Research.
[4] J. Yun,et al. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1. , 2014, Carcinogenesis.
[5] Yingnan Sun,et al. miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma , 2014, Molecular and Cellular Biochemistry.
[6] Guoqiang Zhao,et al. MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma , 2013, Cellular Oncology.
[7] D. Chung,et al. miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis. , 2013, Surgery.
[8] D. Schlaepfer,et al. Src-inducible association of CrkL with procaspase-8 promotes cell migration , 2013, Cell adhesion & migration.
[9] O. De Wever,et al. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells. , 2013, International journal of oncology.
[10] R. Poon,et al. Over-Expression of miR-106b Promotes Cell Migration and Metastasis in Hepatocellular Carcinoma by Activating Epithelial-Mesenchymal Transition Process , 2013, PloS one.
[11] D. Saslow,et al. Cancer screening in the United States, 2013 , 2013, CA: a cancer journal for clinicians.
[12] A. Jemal,et al. Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.
[13] J. Yun,et al. MiR-663, a microRNA targeting p21WAF1/CIP1, promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma , 2012, Oncogene.
[14] X. Zha,et al. Bone metastasis in a novel breast cancer mouse model containing human breast and human bone , 2012, Breast Cancer Research and Treatment.
[15] A. Pasquinelli. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship , 2012, Nature Reviews Genetics.
[16] T. Guise,et al. Cancer to bone: a fatal attraction , 2011, Nature Reviews Cancer.
[17] Christopher G. Hill,et al. Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells. , 2011, Gynecologic oncology.
[18] Zhen Bian,et al. miR-29b regulates migration of human breast cancer cells , 2011, Molecular and Cellular Biochemistry.
[19] Hai Hu,et al. Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. , 2010, Oncology reports.
[20] R. Kutner,et al. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors , 2009, Nature Protocols.
[21] R. Weinberg,et al. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.
[22] N. Lynam‐Lennon,et al. The roles of microRNA in cancer and apoptosis , 2009, Biological reviews of the Cambridge Philosophical Society.
[23] C. Schem,et al. Increased COX2 expression enhances tumor-induced osteoclastic lesions in breast cancer bone metastasis , 2008, Clinical & Experimental Metastasis.
[24] M. Korpal,et al. The emerging role of miR-200 family of MicroRNAs in epithelial-mesenchymal transition and cancer metastasis , 2008, RNA biology.
[25] Thomas D. Schmittgen,et al. Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.
[26] J. Aubin,et al. Breast cancer metastasis in a human bone NOD/SCID mouse model , 2007, Cancer biology & therapy.
[27] Héctor Peinado,et al. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.
[28] K. Livak,et al. Real-time quantification of microRNAs by stem–loop RT–PCR , 2005, Nucleic acids research.
[29] J. Peterse,et al. Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.
[30] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[31] M. Okura,et al. Translocation of CrkL to Focal Adhesions Mediates Integrin-Induced Migration Downstream of Src Family Kinases , 2003, Molecular and Cellular Biology.
[32] C. Contag,et al. Animal models of bone metastasis , 2003, Cancer.
[33] G. Mundy. Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.
[34] I. Fidler,et al. Critical determinants of metastasis. , 2002, Seminars in cancer biology.
[35] J. Griffin,et al. The Adapter Protein Crkl Links Cbl to C3G after Integrin Ligation and Enhances Cell Migration* , 1999, The Journal of Biological Chemistry.
[36] R. Salgia,et al. Involvement of the adapter protein CRKL in integrin-mediated adhesion , 1999, Oncogene.
[37] R Wieser,et al. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. , 1999, The Journal of clinical investigation.
[38] C. Sawyers,et al. The CRKL Adaptor Protein Transforms Fibroblasts and Functions in Transformation by the BCR-ABL Oncogene* , 1996, The Journal of Biological Chemistry.
[39] T. Fioretos,et al. Cellular interactions of CRKL, and SH2-SH3 adaptor protein. , 1994, Cancer research.
[40] K. Kolibaba,et al. Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation. , 1997, Blood.